Comments for: Two arthritis drugs may pose cancer risks

CHICAGO – Rheumatoid arthritis patients taking Humira or Remicade face triple the risk of developing several kinds of cancer and double the risk of getting serious infections, a study led by the Mayo Clinic found. The analysis builds on previous reports about the risks associated… Read More
Read more
By continuing to use this site, you give your consent to our use of cookies for analytics, personalization and ads. Learn more.